CANBRIDGE PHARMACEUTICALS INC. 北海康成製藥有限公司

Pay for financial year ended 2021-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chan, Peng Kuan 陳炳鈞 INED 97 97
2 Chen, Kan (1981) 陳侃 NED
3 Di Rocco, Derek Paul NED
4 Geraghty, James Arthur INED 194 194
5 Gregory, Richard James (1958) INED 194 194
6 Le, Xiao 樂霄 NED
7 Xue, James Qun 薛群 Ch, CEO, Fdr 4,421 128 5,749 10,298
Total 485 4,421 0 128 5,749 10,783

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,292 5,233 0 200 1,675 8,400 Report
2023-12-31 1,271 5,710 0 139 3,696 10,816 Report
2022-12-31 814 4,968 0 125 8,025 13,932 Report
2021-12-31 485 4,421 0 128 5,749 10,783 Report
Total 3,862 20,332 0 592 19,145 43,931

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top